Proline rich tyrosine kinase 2 (Pyk2) on promoting cisplatin resistance of HCC cells through preventing cell apoptosis, activation of AKT pathway and upregulation of drug resistant genes [50]. The gene discussed is PTK2B; the disease is hepatocellular carcinoma.